Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04699799 · ClinicalTrials.gov registry record · NA
Characterization of Human Olfactory Amygdala Subregions
A NA study of Human Olfactory Amygdala, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04699799: Recruiting NA study of Human Olfactory Amygdala, sponsored by Northwestern University.
NCT04699799 is a NA study of Human Olfactory Amygdala that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04699799, a NA study of Human Olfactory Amygdala, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
We aim to better understand the subregions of the human amygdala that receive direct projections from the olfactory bulb
Primary Outcome
We will assess the quantity of input to each amygdala subregion from the olfactory tract
Conditions Studied
Interventions
- OTHER Present odors to participants while recording brain activity
Study Locations (1)
Illinois
- Northwestern human olfaction lab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
What NCT04699799 shows while recruiting
NCT04699799 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Human Olfactory Amygdala appearing as the primary indexed condition, and to 1 intervention - of which Present odors to participants while recording brain activity is the first listed.
NCT04699799 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04699799 about?
NCT04699799 is a clinical study titled "Characterization of Human Olfactory Amygdala Subregions". We aim to better understand the subregions of the human amygdala that receive direct projections from the olfactory bulb
What is the current status of trial NCT04699799?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-01-01. Estimated completion is 2026-04-01.
What conditions does trial NCT04699799 study?
This clinical trial studies the following conditions: Human Olfactory Amygdala.
What interventions are being tested in trial NCT04699799?
The interventions under investigation include: Present odors to participants while recording brain activity (OTHER).
Who is sponsoring clinical trial NCT04699799?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04699799 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04699799's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI